The Indonesian Embassy in Amman together with the Food and Drug Monitoring Agency (BPOM) on 5-6 October 2019 organized Training on Good Regulatory Practice in Medicines within the framework of the South-South Cooperation Program between Indonesia’s Food and Drug Authority, the National Medicine Regulatory Authorities of the State of Palestine and Jordan Food and Drug Administration.
The training was attended by 18 participants from drug control authorities and Palestinian and Jordanian pharmaceutical businesses. During the training, a business meeting was held between Indonesian pharmaceutical industry companies and importers of Jordanian and Palestinian medicines.
After the opening ceremony of the training, Indonesian Ambassador Amman, Andy Rachmianto, and To BPOM, Penny K. Lukito, witnessed the signing of a Memorandum of Understanding (MoU) between pharmaceutical companies Dexa Medica and Al Noor Drugs Store (Jordan) for the supply of diabetes drugs, some injection products and modern herbal medicine. In addition, Dexa Medica signed MuO with Annajah Medical Company & Pharmaceutical (Palestine), to import modern herbal medicine products from Indonesia.
Krestijanto Pandji, President Director of PT. Ferron Pharmaceuticals-Dexa Group expressed its gratitude to the Indonesian Embassy in Amman for fully supporting Dexa Medica in opening the medicine market in Jordan and Palestine.
With these two agreements, Dexa Medica has officially opened a representative office in Amman, Jordan to handle market areas throughout the Middle East and North Africa to complete the representative office which was opened earlier for the West African and Central African markets.
After the opening of the training and signing of the MoU, the Head of BPOM hoped that Jordan and Palestine would not only be able to increase the capacity of drug control authorities and market participants in the Palestinian and Jordanian medicines, but also to introduce and market Indonesian pharmaceutical products.
On the same occasion, the Indonesian Ambassador in Amman said that the Indonesian Embassy would continue to oversee, maintain and increase commitment in supporting cooperation and capacity building for Palestine. Ambassador Andy hopes that Dexa Medica and other pharmaceutical industry companies will be able to use Jordan as a hub to open up potential market distribution channels in the Middle East and take advantage of Jordan’s free trade agreement (FTA) agreements with other countries such as the United States, the European Union and Canada.
“Collaboration of the pharmaceutical industry with partners from
Jordan and Palestine is a collaboration to strengthen bilateral relations between countries with the spirit of “Indonesia Incorporated,” Ambassador Andy stressed.